Dolphin Medical, a company in the Healthcare Service Provider industry, reported revenue of ₹0.41 crore and net profit of ₹0.02 crore for the September 2026 quarter.
Dolphin Medical (BSE: DOLPHMED) closed at ₹7.83 on 16 Nov 2026, up 278.3% over the past year. Its market capitalisation is ₹12 crore and it trades at 197.0 times earnings.
Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and other allied services.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.